drugset / Trial / NCT00279916

Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays

NCT00279916

Phase 3 Completed 91 enrolled Mayo Clinic Aventis Pharmaceuticals · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

We hypothesize that intranasal steroid application will have a beneficial therapeutic effect in adults with regard to resolution of serous otitis media and/or negative middle ear pressure, as compared to placebo. We further hypothesize that the rate of spontaneous short-term resolution of otitis media wit effusion in adults treated with placebo will be relatively low (minority of patients).

Timeline

Start
2005-09-01
Primary completion
2009-02
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Acetonide Other / unclassified 110 ug Intranasal
Comparator Triamcinolone Acetonide Other / unclassified 220 ug Intranasal